Challenges for U.S. Attorneys’ Offices (USAO) in Opioid Cases

US Attorney Office White Paper

On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being created to identify any prescribers and pharmacies that may be dispensing and/or prescribing a disproportionate number of opioids.

To further support the initiative and assure that the data from the new tracking system results in effective prosecutions, Mr. Sessions committed 12 federal prosecutors to the 12 districts where the epidemic is at its worst. Every U.S. Attorney was charged to designate an Opioid Coordinator by December 15, 2017. Click to continue reading white paper.

Let's Talk About Solutions

How can Qlarant help you improve quality and program performance?